CopyMark Law Group
4.9/5
Drawing for Serial No. 79309084

USPTO serial 79309084

Serial No. 79309084

Reviewed by CopyMark Law Group

Reg. 6733792Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
SMITH, CYNTHIA RINALDI
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79309084?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Adriano Pacifici

Adriano Pacifici Intellectual Property Consulting, LLC400 Poydras StreetSuite 1400New Orleans, LA 70130

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for human purposes, namely, medicines for treating lymph cancer, leukemia, multiple myeloma, myelodysplasia syndrome, cystadenocarcinoma, breast cancer, lung cancer, liver cancer, intestinal cancer, stomach cancer, nasopharyngeal cancer, skin cancer, diabetes and antiviral medicine preparations; chemical preparations for pharmaceutical purposes, namely, antivirals; capsules sold empty for pharmaceuticals; pharmaceutical preparations for treating lymph cancer, leukemia, multiple myeloma, myelodysplasia syndrome, cystadenocarcinoma, breast cancer, lung cancer, liver cancer, intestinal cancer, stomach cancer, nasopharyngeal cancer, skin cancer, diabetes; dietetic substances, namely, dietetic foods adapted for medical use; medicines for veterinary purposes, namely, veterinary preparations for pigs, cattle and sheep for use in the treatment of intestinal bacteriaACTIVE—
035Advertising services; marketing research; import-export agency services; retail and wholesale store services featuring pharmaceutical preparations, veterinary preparations, sanitary preparations, and medical suppliesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 9, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 2, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 2, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 9, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 9, 2022FIMPFINAL DISPOSITION PROCESSED—
Aug 24, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 24, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 24, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 13, 2022GPNXNOTIFICATION PROCESSED BY IB—
Mar 8, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 8, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 16, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 16, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 16, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 2, 2022PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 31, 2022ALIEASSIGNED TO LIE—
Jan 31, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 28, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 27, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 27, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 23, 2021RFNTREFUSAL PROCESSED BY IB—
Oct 28, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 28, 2021RFRRREFUSAL PROCESSED BY MPU—
Oct 2, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 1, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2021DOCKASSIGNED TO EXAMINER—
Apr 24, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 20, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 19, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Apr 15, 2021SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance